Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. - Wikidata - awgldk - TriplyDB

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.

http://www.wikidata.org/entity/Q44777880

about

Chronic Pancreatitis and Pancreatic Cancer Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice Lack of PPARα exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.PPARs Mediate Lipid Signaling in Inflammation and Cancer.Rosiglitazone attenuates the severity of hyperlipidemic severe acute pancreatitis in rats.Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.Diabetes, insulin, and development of acute lung injury.Therapeutic Potential of PPARγ Activation in Stroke.Rosiglitazone promotes pancreatic regeneration in experimental model of acute pancreatitis.Peroxisome proliferator-activated receptor gamma agonist reduces the severity of post-ERCP pancreatitis in rats.Therapeutic administration of orlistat, rosiglitazone, or the chemokine receptor antagonist RS102895 fails to improve the severity of acute pancreatitis in obese mice.Activation of lung macrophage subpopulations in experimental acute pancreatitis.

P2860

Q27025915-ADF0D32A-CC9B-4B8C-8011-EFDBA676571E Q34345441-BAA346B3-BFAC-4333-998E-48BD35882160 Q34664393-B8BD37AE-68EE-4FD0-BB83-171655D47D28 Q35083721-7BC9A411-78F5-4801-9175-FBE4589D9126 Q36420744-45A9B15D-32E5-42A1-9006-4CECD852781A Q36445381-C7FE4A6A-C916-4B27-BEA7-3F9548778640 Q36591722-C3E87F3C-C091-48E2-8BC3-288DDADD92E9 Q36992256-457631AC-4329-40C0-A5ED-984FC233E2C3 Q37021709-F62765A8-F4C7-40A4-AC7C-0BE0693049DE Q37231249-02CCE61B-4255-4FA2-858A-BB84D155BE4D Q37376937-B8F4A59C-AE90-4076-BB2C-C9275A6A7F8C Q37457675-49DFEDA6-E444-4FCB-BB87-604FF4F2D172 Q37521491-7D84BCF2-F6B2-4FDC-B85F-B53760A5C54D Q37930425-C8BEF55D-A138-43C9-815D-AC2E6BE1DB21 Q39880827-EBC04CC3-971B-4E41-969C-BD51A2B522E8 Q41952635-2C36FF56-69E0-4C19-9CC9-805E92FD042D Q42854940-6F512538-8A39-4D2E-B165-365C63E9E44C Q54396428-3F39DBC2-F609-43A3-9567-A828670F2A5B

P2860

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.

http://www.wikidata.org/entity/Q44777880

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@en

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@nl

type

label

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@en

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@nl

prefLabel

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@en

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@nl

P1433

Q44777880-B85AC716-8572-4F3F-9270-254B1A0F39E9

P1476

Q44777880-CC000A27-7D1E-4E55-A2D3-A1D194F951FA

P2093

Q44777880-0AF91A12-11E7-4F87-AECC-7E0FA9B9B5E5

Q44777880-2E81C43B-D31D-4AF3-ACD6-A03C203EDFD9

Q44777880-3E93DB0E-F84C-4EB9-97A0-7CDD2FC658E2

Q44777880-6450FF0C-864D-48FB-8D0E-CD4C2A63D8F3

Q44777880-B43B2594-A74E-4AF9-89B5-6B7D08644F5D

Q44777880-E83B881A-BFF3-4B1F-A030-6F56AAE398DA

P2888

Q44777880-DB5B5B7D-2D73-4B3E-AC5F-2F5364847ACA

P304

Q44777880-23A30D38-F4A5-4EC0-B33E-1A7D827CA883

P31

Q44777880-A69710B4-57DC-449E-B7D2-FBED06136C13

P356

Q44777880-D8F67AAF-9924-4A24-8E39-D037DC296357

P433

Q44777880-23C57733-B086-4E6A-8FF1-0C3009C74755

P478

Q44777880-038B6464-4F52-4B3C-BB3A-57065FDCA59F

P50

Q44777880-0B948D4B-1184-43CC-8408-EE60598437F2

Q44777880-12FB8922-20FA-4BB3-AD47-0E6679579674

Q44777880-C574FEF7-79C6-4C61-9AAB-E2DF66B84D97

Q44777880-FC532891-DB90-424A-88F6-4F7D400B7361

Q44777880-FCF917B0-967C-4084-92A1-4A0D2A2F07DE

P577

Q44777880-8E2F95E1-53D0-48A5-BEDB-990D9A9D9945

P698

Q44777880-44A39125-685A-4955-A2FB-562339D26EF3

P356

S00134-004-2180-1

P1433

Intensive Care Medicine

P1476

Rosiglitazone, a ligand of the ...... creatitis induced by cerulein.

@en

P2093

Achille P Caputi

http://www.w3.org/2001/XMLSchema#string

Angela Ianaro

http://www.w3.org/2001/XMLSchema#string

Barbara Pisano

http://www.w3.org/2001/XMLSchema#string

Domenico Britti

http://www.w3.org/2001/XMLSchema#string

Massimo Di Rosa

http://www.w3.org/2001/XMLSchema#string

Nimesh S A Patel

http://www.w3.org/2001/XMLSchema#string

P2888

s00134-004-2180-1

P304

951-956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00134-004-2180-1

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Salvatore Cuzzocrea

Rosanna Di Paola

Tiziana Genovese

Christoph Thiemermann

P577

2004-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14985957

http://www.w3.org/2001/XMLSchema#string